Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Aedifica is a Belgian healthcare real estate investment trust specializing in European senior housing and care facilities across Belgium, Netherlands, Germany, UK, Ireland, Finland, Sweden, Spain, and Portugal. The company owns approximately 600+ properties totaling ~4.5 million square meters, leased primarily to established healthcare operators under long-term triple-net leases (15-25 year terms). Its competitive moat derives from specialized healthcare real estate expertise, scale advantages in fragmented European markets, and relationships with quality operators in a sector with structural demographic tailwinds.
Aedifica generates predictable cash flows through long-term triple-net leases where tenants (healthcare operators) pay base rent plus all property operating expenses, maintenance, insurance, and taxes. Leases typically include annual indexation clauses (CPI-linked, often 1.5-2.5%) providing inflation protection. The company creates value through acquisitions of stabilized assets at 5-6% initial yields, development projects targeting 6-7% yields on cost, and portfolio optimization. Pricing power stems from limited competition for institutional-grade healthcare real estate and operators' need for purpose-built facilities in prime locations near hospitals and residential areas. The 94% gross margin reflects the triple-net lease structure with minimal direct operating costs.
Acquisition pipeline execution and deployment of capital at accretive yields (target €500M-800M annually)
Occupancy rates and lease renewal success across the 600+ property portfolio (currently ~98-99% occupied)
Financing costs and ability to access debt/equity capital markets at favorable terms (current debt/equity 0.68 suggests moderate leverage)
Regulatory changes in healthcare reimbursement across key markets (Belgium, Netherlands, Germany represent ~70% of portfolio)
Tenant credit quality and operator financial health (concentration risk with top 10 tenants representing ~40-50% of rents)
Regulatory risk from government healthcare policy changes across nine European countries, including reimbursement rate cuts, staffing mandates, or quality standards that pressure operator profitability and ability to pay rent
Demographic shifts or medical advances that reduce demand for institutional care in favor of home-based care or technology-enabled aging-in-place solutions
ESG and sustainability requirements driving costly retrofits for energy efficiency, accessibility standards, and climate adaptation across aging property portfolio
Increasing competition from larger global healthcare REITs (Welltower, Ventas expanding in Europe) and private equity capital driving down acquisition yields and compressing returns
Tenant vertical integration risk as large healthcare operators (Orpea, Korian, DomusVi) acquire their own real estate, reducing demand for sale-leaseback transactions
Development risk from construction cost inflation and permitting delays impacting pipeline economics and ability to meet 6-7% yield-on-cost targets
Refinancing risk with 0.68 debt/equity ratio and likely €1.5-2B debt outstanding requiring access to capital markets; rising rates increase interest expense and reduce coverage ratios
Currency exposure across nine countries creates translation risk and complicates hedging strategies, though natural hedges exist with local currency debt
Concentration risk with top tenants representing significant rent exposure; single operator default could materially impact cash flows and require asset repositioning
low - Healthcare real estate demonstrates defensive characteristics as demand for senior housing and care facilities is driven by demographics (aging population) rather than economic cycles. Occupancy rates remain stable through recessions as elderly care is non-discretionary. However, new supply can be cyclical as development financing tightens during downturns. Government healthcare spending (50-70% of operator revenues across Europe) provides additional stability.
Rising interest rates negatively impact Aedifica through three channels: (1) Higher financing costs on floating-rate debt and refinancings reduce distributable cash flow, (2) Cap rate expansion compresses property valuations and NAV, (3) Higher risk-free rates make REIT dividend yields less attractive relative to bonds, pressuring valuation multiples. The 0.68 debt/equity ratio and likely 40-50% floating rate exposure create meaningful sensitivity. Conversely, CPI-linked rent escalators provide partial inflation hedge. The current 19.6x EV/EBITDA suggests valuation vulnerability to rate increases.
Moderate - Aedifica's access to debt capital markets at favorable terms is critical for funding acquisitions and refinancing maturing debt. Widening credit spreads increase borrowing costs and can force equity issuance at dilutive prices. Tenant credit quality matters as operator bankruptcies require re-leasing efforts and potential rent reductions. However, the specialized nature of healthcare facilities and long lease terms provide some insulation from credit market volatility.
dividend - Aedifica attracts income-focused investors seeking stable, growing dividends backed by long-term lease cash flows and demographic tailwinds. The 5.9% FCF yield and 66% net margin support distributions. Defensive characteristics appeal to risk-averse investors during economic uncertainty. The 51.8% one-year return suggests recent momentum interest, but core holders are typically long-term income investors and European pension funds seeking inflation-protected real estate exposure.
moderate - Healthcare REITs exhibit lower volatility than equity markets due to stable cash flows, but higher than government bonds. Interest rate sensitivity creates volatility during monetary policy shifts. The 17.8% six-month return and 0.07 current ratio (typical for REITs distributing most cash flow) suggest moderate price swings. Beta likely 0.6-0.8 relative to European equity indices.
